State Street Corporation 13D and 13G filings for Altimmune, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-17 11:16 am Sale |
2024-09-30 | 13G | Altimmune, Inc. ALT |
STATE STREET CORP STT |
3,413,827 4.800% |
-495,459 (-12.67%) |
Filing |
| 2024-07-10 06:35 am Sale |
2024-06-30 | 13G | Altimmune, Inc. ALT |
STATE STREET CORP STT |
3,909,286 5.510% |
-4,739,984 (-54.80%) |
Filing |
| 2024-04-10 09:40 am Purchase |
2024-03-31 | 13G | Altimmune, Inc. ALT |
STATE STREET CORP STT |
8,649,270 12.200% |
7,634,724 (+752.53%) |
Filing |
| 2024-01-23 10:50 am Purchase |
2023-12-31 | 13G | Altimmune, Inc. ALT |
STATE STREET CORP STT |
1,014,546 1.890% |
210,473 (+26.18%) |
Filing |
| 2023-07-10 2:31 pm Sale |
2023-06-30 | 13G | Altimmune, Inc. ALT |
STATE STREET CORP STT |
804,073 1.630% |
-5,110,515 (-86.41%) |
Filing |
| 2023-01-10 08:00 am Purchase |
2022-12-31 | 13G | Altimmune, Inc. ALT |
STATE STREET CORP STT |
5,914,588 12.030% |
5,223,447 (+755.77%) |
Filing |
| 2022-04-11 1:42 pm Sale |
2022-03-31 | 13G | Altimmune, Inc. ALT |
STATE STREET CORP STT |
691,141 1.600% |
-3,730,400 (-84.37%) |
Filing |
| 2022-02-11 07:38 am Purchase |
2021-12-31 | 13G | Altimmune, Inc. ALT |
STATE STREET CORP STT |
4,421,541 11.130% |
430,400 (+10.78%) |
Filing |
| 2021-09-10 2:19 pm Purchase |
2021-08-31 | 13G | Altimmune, Inc. ALT |
STATE STREET CORP STT |
3,991,141 10.050% |
3,991,141 (New Position) |
Filing |